Edgewell Personal Care Co
Statements
Segments
US companies must disclose in their mandatory reports how revenue breaks down across business segments, regions and product lines. We read that breakdown for you straight from the annual and quarterly reports (10-K and 10-Q) of Edgewell Personal Care Co (EPC). It shows which part of the business is growing — and which one is holding it back.
Revenue by business segment
| Segment | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Wet Shave | $1.16B 59.6% | $1.22B 58.3% · +4.6% | $1.24B 57.2% · +2.2% | $1.23B 54.7% · -0.9% | $1.23B 62.4% · -0.1% | $1.22B 62.1% · -0.8% | $1.22B 61.3% · +0.4% |
| Sun and Skin Care | $462.0M 23.7% | $585.3M 28.0% · +26.7% | $638.5M 29.4% · +9.1% | $705.5M 31.3% · +10.5% | $740.8M 37.6% · +5.0% | $743.1M 37.9% · +0.3% | $772.5M 38.7% · +4.0% |
| Feminine Care | $298.6M 15.3% | $286.1M 13.7% · -4.2% | $290.7M 13.4% · +1.6% | $315.2M 14.0% · +8.4% | – | – | – |
| All Other | $26.8M 1.4% | – | – | – | – | – | – |
| Operating segments | – | – | – | – | – | – | – |
| segment profit | – | – | – | – | – | – | – |
Large figure: segment revenue. Below it the share of revenue in that period and the change against the prior year.
| Segment | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Wet Shave | $206.2M 17.7% | $221.5M 18.2% | $174.5M 14.0% | $158.3M 12.9% | $203.9M 16.6% | $190.3M 15.6% | $164.7M 13.5% |
| Sun and Skin Care | $69.1M 15.0% | $99.0M 16.9% | $108.8M 17.0% | $137.4M 19.5% | $131.3M 17.7% | $98.4M 13.2% | $109.2M 14.1% |
| Feminine Care | $52.3M 17.5% | $37.5M 13.1% | $31.5M 10.8% | $49.7M 15.8% | – | – | – |
| All Other | $3.1M 11.6% | – | – | – | – | – | – |
| Operating segments | $330.7M | $358.0M | $314.8M | $345.4M | $335.2M | – | – |
| segment profit | – | – | – | $345.4M | – | $288.7M | $273.9M |
Large figure: segment operating income. Below it the margin, that is operating income measured against the revenue of the same segment.
Revenue by region
| Segment | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| International | $866.9M 44.5% | $903.7M 43.3% · +4.2% | $865.2M 39.8% · -4.3% | $925.5M 41.1% · +7.0% | $961.2M 48.8% · +3.9% | $991.5M 50.5% · +3.2% | $1.02B 50.9% · +2.6% |
| United States | $1.08B 55.5% | $1.18B 56.7% · +9.3% | $1.31B 60.2% · +10.4% | $1.33B 58.9% · +1.5% | $1.01B 51.2% · -23.9% | $970.5M 49.5% · -3.8% | $979.4M 49.1% · +0.9% |
Large figure: segment revenue. Below it the share of revenue in that period and the change against the prior year.
Revenue by product line
| Segment | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Razors and blades | $1.02B 52.5% | $1.08B 52.0% · +6.0% | $1.11B 51.1% · +2.2% | $1.10B 49.0% · -0.5% | $1.11B 56.4% · +0.7% | $1.10B 56.3% · -0.6% | $1.10B 55.3% · +0.0% |
| Sun care products | $283.3M 14.5% | $333.6M 16.0% · +17.8% | $401.8M 18.5% · +20.4% | $450.7M 20.0% · +12.2% | $483.6M 24.5% · +7.3% | $458.9M 23.4% · -5.1% | $463.2M 23.2% · +0.9% |
| Grooming products | – | – | – | – | – | $200.6M 10.2% | $227.8M 11.4% · +13.6% |
| Shaving gels and creams | $139.0M 7.1% | $131.3M 6.3% · -5.5% | $133.7M 6.2% · +1.8% | $127.3M 5.7% · -4.8% | $118.3M 6.0% · -7.1% | $114.2M 5.8% · -3.5% | $119.4M 6.0% · +4.6% |
| Wipes and other skin care products | – | – | – | – | – | $83.6M 4.3% | $81.5M 4.1% · -2.5% |
| Tampons, pads and liners | $298.6M 15.3% | $286.1M 13.7% · -4.2% | $290.7M 13.4% · +1.6% | $315.2M 14.0% · +8.4% | – | – | – |
| Skin care products | $178.7M 9.2% | $102.8M 4.9% · -42.5% | $78.0M 3.6% · -24.1% | $82.3M 3.7% · +5.5% | $74.3M 3.8% · -9.7% | – | – |
| Infant care and other products | $26.8M 1.4% | $148.9M 7.1% · +455.6% | $158.7M 7.3% · +6.6% | $172.5M 7.7% · +8.7% | $182.9M 9.3% · +6.0% | – | – |
Large figure: segment revenue. Below it the share of revenue in that period and the change against the prior year.
Segment and region names are the ones the company itself uses and are shown as reported. Change and share refer to revenue.
Data as of: November 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Segment figures: SEC EDGAR (10-K/10-Q reports)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.